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Abstract 
Our case was a 65-year-old male, with the chief complaints of diarrhea and abdominal 
distention. Three years earlier, the patient had undergone transcatheter arterial 
embolization and radiofrequency treatment based on a diagnosis of hepatocellular 
carcinoma due to hepatitis B by another doctor. In October 2007, the patient developed 
diarrhea and increased abdominal distention. In December, CT examination conducted 
by the previous doctor revealed a 20-cm tumor within the pelvis. The patient was 
diagnosed with sigmoid colon cancer based on barium enema examination using 
gastrografin, and was introduced to our hospital for treatment. He was diagnosed with 
low-differentiated carcinoma by biopsy of the colon during endoscopy and underwent 
sigmoidectomy based on a diagnosis of sigmoid colon cancer. The tumor had infiltrated 
the bladder, and a tumorectomy was conducted through partially combined resection. 
The tumor was a huge lesion occupying the inside of the lumen, and histopathological 
findings revealed that the tumor, the main part of which lay beneath the mucous 
membrane, had a transitional image composed of both spindle-shaped atypical cells and 
sarcomatoid shape. The result of immunostaining was CK7(+), CK20(–), AFP(–), and the 
patient was diagnosed as having carcinosarcoma of the colon. Carcinosarcoma of the 
colon is a malignant tumor with poor prognosis, and the mean survival period in past 
reports was approximately 6 months. The patient was treated with FOLFIRI+Bevacizumab 
therapy according to chemotherapy for colon cancer, but he was refractory to the 
therapy.  
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Introduction 
Carcinosarcoma is a relatively rare tumor characterized by a mixed composition of 
malignant epithelial and mesenchymal components with a poor prognosis. This tumor 
occurs in various anatomic locations such as head and neck, respiratory tract, uterus, 
ovaries and other sites. Within the digestive tract, it is most often seen in the esophagus. 
Carcinosarcoma of the colon was first reported by Weidner and Zekan in 1986 [1], and 
since then fewer than 20 cases have been reported. In this paper we report a case with 
carcinosarcoma of the colon found during treatment for hepatic cancer. Carcinosarcoma 
of the colon is a very rare disease and we discuss it with reference to the literature. 
Case Report 
The patient was a 65-year-old male presenting with the chief complaints of feeling of oppression in 
the lower abdomen and diarrhea. He had a past history of hepatitis B, hepatic cell carcinoma and 
hypertension. His family history was unspecific. Diarrhea occurred from October 2007, and abdominal 
distention developed from December. The patient had been diagnosed as having colon cancer by the 
previous doctor. He visited us for surgery and treatment, wished to undergo surgery in our hospital, and 
so was admitted. His height was 167.3 cm and his weight was 58.0 kg. Nutritional state was slightly poor. 
Blood pressure was 88/59 mm Hg, pulse rate was 96 bpm and regular, and the bulbar conjunctiva and 
palpebral conjunctiva were normal. There was no swelling of superficial lymph nodes. The abdomen 
was swollen and a mass was palpated in the lower abdomen. Findings on admission were: anemia with 
Hb 10.2 g/dl, CEA 2.3 IU/ml, CA19-9 36.0 ng/ml and AFP 18.0 ng/ml. Barium enema examination 
showed a mass being compressed from the outside of the wall in the sigmoid colon (fig. 1). Colon 
endoscopy revealed a smooth granulation-like mass with glazed surface projecting within the lumen at 
about 15 cm from the anal verge (fig. 2). The tumor was elastic and soft, and it was difficult to insert the 
fiber through it to the oral bowel. In an image of the tumor tissue by biopsy, proliferation of atypical 
cells was observed in part of the degenerated or necrotic tissues, which was diagnosed as 
undifferentiated cancer. Immunostaining was additionally conducted and was positive for cytokeratin 7 
and negative for cytokeratin 20, hepatocyte and AFP. CT revealed a mass of approximately 15 cm within 
the pelvis whose inside was inhomogeneous and whose boundary was comparatively distinct. Contrast 
effect was observed on the margins. There were no distinct infiltrations into the other organs (fig. 3). 
MRI also depicted it as a mass with a distinct boundary and inhomogeneous inside. Based on the above 
findings, surgery was conducted under the diagnosis of undifferentiated cancer of the colon. 
Surgical findings showed that the mass originated from the sigmoid colon, and part of it infiltrated 
the bladder, so part of the bladder was resected together with the mass. Intraoperatively, a small white 
nodule was observed in part of the greater omentum, which was diagnosed as peritoneal semination by 
intraoperative rapid diagnosis. None of the 26 extracted lymph nodes developed metastasis, and surgical 
stage was SiN0H0P1M(–), stage IV according to the General Rules for Clinical and Pathological Studies 
on Cancer of the Colon, Rectum and Anus. The solid cut surface of the lesion showed that the tumor 
was submucosal and part of it became necrotic with bleeding (fig. 4). 
The HE finding revealed that atypical epithelial cells had various sizes of duct structure, forming an 
alveolar structure. Partly spindle-shape atypical cells had proliferated and formed a sarcomatoid shape, 
but there were no ectopic mesenchymal components of bone, cartilage, and striated muscle. There was a 
transitional zone, though slightly indistinct, between the epithelial tumor part and mesenchymal tumor 
part with a component ratio of 9:1 between the former and the latter (fig. 5). Immunostaining was 
positive for cytokeratin 7, negative for cytokeratin 20, partially positive for hepatocyte, which is a 
marker of hepatic cell cancer, negative for AFP, and negative for PAS, which is a marker of mucinous 
carcinoma, thus disproving colon metastasis of hepatic cell cancer. hCG was negative and so there was 
no possibility of germinoma. Based on the above, the disease was diagnosed as low-differentiated tumor 
showing differentiation into various tissues such as glandular epithelium or hepatic cells. The diagnosis 
according to the General Rules for Clinical and Pathological Studies on Cancer of the Colon, Rectum 
and Anus was SE, int, INFb, ly0, v2, n0(0/26), H0, P1, M(–), stage IV.  
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Postoperatively the patient was discharged from the hospital 44 days after surgery without 
postoperative complications. He had orally been administered capecitabine 3,000 mg/day as adjuvant 
chemotherapy, but multiple lung metastases occurred bilaterally at 6 months after surgery. 
Chemotherapy of FOLFIRI+Bevacizumab was started and 8 cycles were conducted, but the effect was 
determined as PD, and the patient died on October 21, 2008. 
Discussion 
Carcinosarcoma of the colon is a malignant tumor composed of both carcinoma and 
sarcoma components. In the literature, carcinosarcoma occurring in the colon was first 
reported by Weidner and Zekan in 1986 [1]. To our knowledge, there have been reports 
of 19 cases to date (table 1). The mean age of patients was 69.1 years without any 
difference between males and females. No significant difference was observed in the ratio 
between carcinoma and sarcoma components. Lesions of carcinosarcoma were found in 
various places including the abdominal organs, skin, lung, mammary gland, eye, and head 
or neck, but its pathopoiesis remains unclear when compared with other malignant 
tumors. The mean survival period was as short as 6 months, showing extremely poor 
prognosis (fig. 6). The subject in this study was treated with positive chemotherapy upon 
occurrence of lung metastasis, but died 5 months later. 
There are three histological theories: collision theory, composition theory, and 
combination theory. The combination theory has two subtheories: the metaplastic tumor 
theory which considers that the sarcoma component is secondarily derived from 
carcinoma, and the conversion tumor theory. With regard to carcinosarcomas which 
develop in the digestive system organs, the metaplastic theory is supported, which 
explains that in most cases, the carcinoma component precedes and that it is 
differentiated into the sarcomatoid component in accordance with the development of 
cancer clones [21]. A similar finding was reported for carcinosarcomas in the lung or 
bladder [22, 23]. Analyses of the inactivation pattern of X chromosome, P53, and LOH 
clarified that many patients with carcinosarcoma had combination tumor deriving from a 
single clone. A past report described that the epithelial component and sarcoma 
component of carcinosarcoma in the colon were classified into a weak positive sarcoma 
component, osteosarcomatoid component, and chondrosarcoma component without the 
former two components by staining cytokeratin using HE staining and immunostaining 
methods, and their prognoses were compared. Aramendi et al. [15] reported that there 
was heterologous differentiation in the osteo- and chondrosarcomatous areas and the 
prognosis of this group was uniformly dismal, and that in most cases, the timing of 
operation was correlated with its prognosis, and there was no case affecting the prognosis, 
though chemotherapy and radiotherapy were conducted after tumorectomy. In this 
patient, heterologous differentiation of osteo- and chondrosarcomatous areas was 
observed in the mesenchymal component. With regard to chemotherapy, 5-FU FL 
therapy (UFT+leucovorin), and capecitabine, or MMC, cisplatin have been administered 
to patients with metastasis in lymph nodes in accordance with colon cancer therapy, but a 
satisfactory treatment effect has not been obtained as yet [1, 6, 8, 12, 13, 18]. This patient 
had been orally administered capecitabine as postoperative adjuvant chemotherapy, but 
multiple lung metastases were observed by PET examination conducted 6 months after 
surgery. FOLFIRI (5-FU, l-LV, Irinotecan), which is the standard chemotherapy for 
progressive recurrent colon cancer, and Bevacizumab, which is a molecular target drug, 
were administered, but there was no treatment effect and metastatic lesions rapidly  
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increased, and the patient died 10 months after surgery. Currently, the range of choice of 
therapeutic agents for progressive recurrent colon cancer has been spreading because of 
the emergence of molecular target drugs such as cetuximab, and therapeutic agents that 
are effective for carcinosarcoma are expected to become available on the market. 
 
 
 
Table 1. Cases of carcinosarcoma of the colon reported in the literature 
Refer-
ence 
Age/sex Site  Distant 
metastasis 
Component LN 
metastasis 
Out- 
come 
Months Year  First 
author 
01 73/M  S  meta  –  –  dead  48  1986  Weidner 
02 64/M  D  meta  SC>Ca  +  dead  04 1995  Staroz 
03 71/F R  meta  SC>Ca  +  dead  06 1995  Roncaroli 
04 86/F A  none  Ca>SC  –  alive  24  1996  Isimbaldi 
05 40/F C    –    dead  02 1997  Gentile 
06 79/F A  sync  –  +  dead  05 1997  Bertram 
07 69/F D  none  SC>Ca  –  alive  06 1997  Serio 
08 78/M  D  none  –  –  alive  16  1998  Shoji 
09 60/F T  none  SC>Ca  +  alive  14  1998  Nakao 
10 82/M  R  meta  Ca>SC  –  dead  06 2000  Takeyoshi
11 57/F R  sync  SC>Ca  +  dead  05 2001  Shah 
12 41/F S  none  Ca>SC  +  dead  04 2001  Kim 
13 56/F D  meta  –    dead  21  2001  Di  Vizio 
14 80/F R  meta  SC>Ca  +  dead  06 2003  Ishida 
15 84/M  T  none  Ca>SC  –  dead  00 2003  Aramendi 
16 67/F S  meta  –    dead  02 2004  Macaigne 
17 71/M  A  sync  Ca>SC  +  alive  0– 2005  Kim 
18 81/M  A  sync  Ca>SC  +  alive  24  2006  Ambrosini
19 65/F R  none  Ca>SC  –  alive  60  2006  Ozturk 
20 13/F R  meta  SC>Ca  +  alive  04 2008  Jeong 
21 74/M  S  meta  Ca>SC  –  dead  10    this  report
meta = Metachronous; sync = synchronous; SC = sarcoma; Ca = carcinoma; S = sigmoid; 
D = descending; R = rectum; A = ascending; C = cecum; T = transverse. 
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Fig. 1. Barium enema examination showed a mass being compressed from the outside of the wall in 
the sigmoid colon. 
 
 
 
Fig. 2. Colon endoscopy showed a smooth granulation-like mass with glazed surface projecting within 
the lumen at about 15 cm from the anal verge. 
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Fig. 3. Abdominal enhanced CT shows a ring-like enhanced and central heterogeneous tumor in the 
pelvis. 
 
 
 
Fig. 4. The solid cut surface of the lesion showed that the tumor was submucosal and part of it became 
necrotic with bleeding. 
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Fig. 5. There was a transitional zone, though slightly indistinct, between the epithelial tumor part and 
the mesenchymal tumor part. HE. ×25. 
 
 
 
Fig. 6. Overall survival rate of reported cases of carcinosarcoma of the colon. 
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